Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Citi
QuintilesIMS
Chinese Patent Office
Healthtrust
Covington
Mallinckrodt
McKinsey
Baxter

Generated: December 18, 2018

DrugPatentWatch Database Preview

Drug Price Trends for RIFAMPIN

« Back to Dashboard

Drug Price Trends for RIFAMPIN

Average Pharmacy Cost for RIFAMPIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
RIFAMPIN 300 MG CAPSULE 00185-0799-30 0.61039 EA 2018-11-21
RIFAMPIN 300 MG CAPSULE 00185-0799-01 0.61039 EA 2018-11-21
RIFAMPIN 300 MG CAPSULE 00185-0799-05 0.61039 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for RIFAMPIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RIFAMPIN 150MG CAP Golden State Medical Supply, Inc. 61748-0015-11 1X100 94.83 2018-01-01 - 2022-12-31 FSS
RIFAMPIN 300MG CAP Mylan Institutional, Inc. 51079-0890-20 100UD 182.30 1.82300 EA 2017-11-15 - 2022-09-29 FSS
RIFAMPIN 600MG/VIL INJ Fresenius Kabi USA, LLC 63323-0351-20 20ML 130.69 6.53450 ML 2017-09-30 - 2022-09-29 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Baxter
Deloitte
Mallinckrodt
Citi
Argus Health
Cantor Fitzgerald
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.